- Home
- PCRX vs MNTK Comparison
PCRX vs MNTK Comparison
Compare PCRX & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- MNTK
- Stock Information
- Founded
- PCRX 2006
- MNTK 1980
- Country
- PCRX United States
- MNTK United States
- Employees
- PCRX N/A
- MNTK N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- MNTK Natural Gas Distribution
- Sector
- PCRX Health Care
- MNTK Utilities
- Exchange
- PCRX Nasdaq
- MNTK Nasdaq
- Market Cap
- PCRX 1.2B
- MNTK 339.0M
- IPO Year
- PCRX 2011
- MNTK 2021
- Fundamental
- Price
- PCRX $22.90
- MNTK $2.17
- Analyst Decision
- PCRX Buy
- MNTK Hold
- Analyst Count
- PCRX 8
- MNTK 3
- Target Price
- PCRX $28.38
- MNTK $3.33
- AVG Volume (30 Days)
- PCRX 545.0K
- MNTK 212.0K
- Earning Date
- PCRX 07-29-2025
- MNTK 08-07-2025
- Dividend Yield
- PCRX N/A
- MNTK N/A
- EPS Growth
- PCRX N/A
- MNTK N/A
- EPS
- PCRX N/A
- MNTK 0.05
- Revenue
- PCRX $702,772,000.00
- MNTK $179,552,000.00
- Revenue This Year
- PCRX $7.54
- MNTK $2.49
- Revenue Next Year
- PCRX $10.78
- MNTK $26.02
- P/E Ratio
- PCRX N/A
- MNTK $42.53
- Revenue Growth
- PCRX 3.08
- MNTK N/A
- 52 Week Low
- PCRX $11.16
- MNTK $1.68
- 52 Week High
- PCRX $27.64
- MNTK $6.13
- Technical
- Relative Strength Index (RSI)
- PCRX 35.82
- MNTK 47.04
- Support Level
- PCRX $22.82
- MNTK $2.22
- Resistance Level
- PCRX $23.83
- MNTK $2.78
- Average True Range (ATR)
- PCRX 0.74
- MNTK 0.19
- MACD
- PCRX -0.02
- MNTK -0.02
- Stochastic Oscillator
- PCRX 6.22
- MNTK 27.38
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.